Cogent Biosciences, Inc. (COGT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -86.88M | -79.11M | -64.29M | -54.54M | -66.51M | -60.58M | -51.98M | -42.7M | -52.53M | -44.07M | -37.97M | -32.07M | -39.52M | -29.41M | -34.44M | -26.46M | -28.33M | -20.78M | -14.11M | -12.51M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -30.63% | -30.59% | -23.66% | -27.73% | -26.62% | -37.46% | -36.9% | -33.17% | -32.93% | -49.86% | -10.25% | -21.2% | -39.47% | -41.54% | -144.1% | -111.46% | -149.29% | -121.83% | -37.42% | -50.3% |
| Net Income | -97.35M | -102.49M | -80.93M | -73.53M | -71.99M | -67.93M | -70.63M | -58.95M | -58.35M | -54.37M | -55.38M | -44.08M | -38.59M | -39.62M | -35.06M | -34.93M | -30.63M | -24.91M | -19.08M | -16.55M |
| Depreciation & Amortization | 1.16M | 1.18M | 1.15M | 1.16M | 1.14M | 1.16M | 1.1M | 1.08M | 1.07M | 794K | 855K | 1.22M | 723K | 937K | 3.71M | 97K | 69K | 68K | 48K | 14K |
| Stock-Based Compensation | 16.91M | 0 | 10.6M | 9.72M | 10.01M | 0 | 10.36M | 10.01M | 9.39M | 8.85M | 8.76M | 7.16M | 5.85M | 5.04M | 4.62M | 0 | 4.17M | 3.85M | 3.46M | 2.59M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -767K | 22.08M | 133K | 279K | -955K | 7.32M | -6.2M | 2.58M | -1.4M | -4.29M | 909K | -737K | -2.74M | -2.54M | -852K | 5.6M | 0 | 0 | 0 | 0 |
| Working Capital Changes | -6.83M | 132K | 4.76M | 7.83M | -4.72M | -1.13M | 13.39M | 2.58M | -3.24M | 4.94M | 6.89M | 4.37M | -4.76M | 6.78M | -6.86M | 2.78M | -1.94M | 215K | 1.46M | 1.43M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 4.24M | -6.53M | -596K | 2.47M | 2.14M | -3.05M | 6.09M | -6.59M | 4.91M | 787K | 2.71M | 2.99M | -1.67M | 1.75M | 601K | -523K | 532K | -866K | 2.36M | 1.68M |
| Cash from Investing | -36.46M | -322.77M | -155.05M | 8.91M | 69.38M | 61.67M | 60.19M | -84.63M | 1.04M | 10.49M | -90.54M | -77.66M | 59.88M | 28.41M | -151.54M | -1.14M | -441K | -433K | -1.16M | -123K |
| Capital Expenditures | -449K | -811K | -65K | -131K | -547K | -75K | -280K | -148K | -70K | -315K | -121K | -1.26M | -1.1M | -1.97M | -3.31M | -1.14M | -441K | -433K | -1.16M | -123K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 76.4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -76.4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 52.54M | 588.67M | 217.37M | 47.23M | 24.97M | 26K | 624K | -256K | 214.06M | 0 | 1M | 162.09M | 445K | 315K | 990K | 162.12M | 138K | 38.01M | 55K | 0 |
| Debt Issued (Net) | 0 | 168.15M | -235K | 47.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 52.54M | 469.42M | 217.6M | 5K | 24.25M | 26K | 624K | -256K | 213.7M | 0 | -170K | 161.99M | 445K | 315K | -170K | 162.12M | 138K | 38.01M | 55K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -48.9M | 0 | 0 | 720K | 0 | 0 | 0 | 356K | 0 | 1.17M | 102K | 0 | 0 | 1.16M | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -70.8M | 186.72M | -2.3M | 1.59M | 27.84M | 1.12M | 8.83M | -127.58M | 162.57M | -33.58M | -127.51M | 52.36M | 20.81M | -682K | -184.99M | 135.77M | -28.64M | 16.8M | -15.22M | -12.63M |
| Free Cash Flow | -87.33M | -79.92M | -64.35M | -54.67M | -67.06M | -60.65M | -52.26M | -42.85M | -52.6M | -44.38M | -38.09M | -33.32M | -40.62M | -31.38M | -37.75M | -27.6M | -28.77M | -21.21M | -15.27M | -12.63M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -30.23% | -31.76% | -23.13% | -27.59% | -27.49% | -36.65% | -37.2% | -28.59% | -29.49% | -41.47% | -0.9% | -20.74% | -41.16% | -47.93% | -147.19% | -118.46% | -153.17% | -126.46% | -48.75% | -51.78% |
| FCF per Share | -1.30 | -1.18 | -0.56 | -0.48 | -0.59 | -0.55 | -0.47 | -0.43 | -0.55 | -0.51 | -0.44 | -0.45 | -0.57 | -0.45 | -0.54 | -0.56 | -0.64 | -0.48 | -0.38 | -0.33 |
| FCF Conversion (FCF/Net Income) | 0.89x | 0.77x | 0.79x | 0.74x | 0.92x | 0.89x | 0.74x | 0.72x | 0.90x | 0.81x | 0.69x | 0.73x | 1.02x | 0.74x | 0.98x | 0.76x | 0.92x | 0.83x | 0.74x | 0.76x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |